Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for Collegium Pharmaceutical (COLL) over the last 2 years, with Dec 2024 value amounting to $92.6 million.

  • Collegium Pharmaceutical's Change in Acquisitions & Divestments fell 50.49% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.3 million, marking a year-over-year decrease of 33.81%. This contributed to the annual value of $92.6 million for FY2024, which is 320.92% up from last year.
  • Collegium Pharmaceutical's Change in Acquisitions & Divestments amounted to $92.6 million in FY2024, which was up 320.92% from $22.0 million recorded in FY2023.
  • Collegium Pharmaceutical's Change in Acquisitions & Divestments' 5-year high stood at $92.6 million during FY2024, with a 5-year trough of $22.0 million in FY2023.
  • Its 2-year average for Change in Acquisitions & Divestments is $57.3 million, with a median of $57.3 million in 2023.
  • Data for Collegium Pharmaceutical's Change in Acquisitions & Divestments shows a peak YoY soared of 320.92% (in 2024) over the last 5 years.
  • Over the past 2 years, Collegium Pharmaceutical's Change in Acquisitions & Divestments (Yearly) stood at $22.0 million in 2023, then surged by 320.92% to $92.6 million in 2024.